| Literature DB >> 24516448 |
Mohammad Zubair Alam1, Farrukh Aqil1, Iqbal Ahmad1, Shamim Ahmad2.
Abstract
This study reports the occurrence of antibiotic resistance and production of β-lactamases including extended spectrum beta-lactamases (ESβL) in enteric bacteria isolated from hospital wastewater. Among sixty-nine isolates, tested for antibiotic sensitivity, 73.9% strains were resistant to ampicillin followed by nalidixic acid (72.5%), penicillin (63.8%), co-trimoxazole (55.1%), norfloxacin (53.6%), methicillin (52.7%), cefuroxime (39.1%), cefotaxime (23.2%) and cefixime (20.3%). Resistance to streptomycin, chloramphenicol, nitrofurantoin, tetracycline, and doxycycline was recorded in less than 13% of the strains. The minimum inhibitory concentration (MIC) showed a high level of resistance (800-1600 μg/mL) to one or more antibiotics. Sixty three (91%) isolates produced β-lactamases as determined by rapid iodometric test. Multiple antibiotic resistances were noted in both among ESβL and non-ESβL producers. The β-lactamases hydrolyzed multiple substrates including penicillin (78.8% isolates), ampicillin (62.3%), cefodroxil (52.2%), cefotoxime (21.7%) and cefuroxime (18.8%). Fifteen isolates producing ESβLs were found multidrug resistant. Four ESβL producing isolates could transfer their R-plasmid to the recipient strain E. coli K-12 with conjugation frequency ranging from 7.0 × 10(-3) to 8.8 × 10(-4). The findings indicated that ESβL producing enteric bacteria are common in the waste water. Such isolates may disseminate the multiple antibiotic resistance traits among bacterial community through genetic exchange mechanisms and thus requires immediate attention.Entities:
Keywords: Antibiotic resistance; ESβL; Enteric bacteria; beta-lactamase; plasmid transfer
Mesh:
Substances:
Year: 2014 PMID: 24516448 PMCID: PMC3910192 DOI: 10.1590/s1517-83822013000300021
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Incidence of antibiotic resistance in the isolates of enteric bacteria.
| Antibiotics | Total no. of resistant isolates (%) | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Miscellaneous (n = 29) | Total (n = 69) | |||||
| Penicillin | 7 (38.9) | 5 (45.5) | 5 (71.4) | 4 (100.0) | 22 (75.7) | 43 (63.8) |
| Ampicillin | 15 (83.3) | 9 (81.8) | 4 (57.1) | 3 (75.0) | 20 (69.0) | 51 (73.9) |
| Cefuroxime | 4 (22.2) | 5 (45.5) | 3 (42.9) | 2 (50.0) | 12 (41.4) | 26 (39.1) |
| Cefixime | 3 (16.7) | 1 (9.1) | 1 (14.2) | 2 (50.0) | 7 (24.1) | 14 (20.3) |
| Cefotaxime | 3 (16.7) | 2 (18.2) | 3 (42.9) | 0 (00.0) | 9 (31.0) | 17 (23.2) |
| Methicillin | 6 (33.3) | 6 (54.5) | 4 (57.1) | 4 (100.0) | 15 (51.7) | 35 (52.7) |
| Nalidixic Acid | 12 (66.7) | 10 (90.9) | 5 (71.4) | 4 (100.0) | 22 (75.9) | 53 (72.6) |
| Cotrimoxazole | 12 (66.7) | 6 (54.5) | 4 (57.1) | 3 (75.0) | 13 (44.8) | 34 (55.7) |
| Norfloxacin | 9 (50.0) | 5 (45.5) | 4 (57.1) | 2 (50.0) | 17 (58.6) | 37 (53.6) |
| Doxycycline | 4 (22.2) | 0 (00.0) | 1 (14.3) | 0 (00.0) | 4 (13.8) | 9 (13.0) |
| Tetracycline | 0 (00.0) | 0 (00.0) | 0 (00.0) | 0 (00.0) | 4 (13.8) | 4 (5.8) |
| Nitrofurantoin | 0 (00.0) | 2 (18.2) | 1 (14.3) | 3 (75.0) | 3 (10.3) | 9 (13.0) |
| Chloramphenicol | 2 (11.1) | 0 (00.0) | 0 (00.0) | 2 (50.0) | 5 (17.2) | 9 (13.0) |
| Streptomycin | 0 (00.0) | 0 (00.0) | 0 (00.0) | 0 (00.0) | 3 (10.3) | 3 (4.4) |
n, number of isolates.
Range of MIC values of antibiotics against test strains
| Antibiotic | % of isolate showing different range of MIC values (μg/mL) | |||
|---|---|---|---|---|
|
| ||||
| ≤25 | 50–100 | 200–400 | 800–1600 | |
| Penicillin | 36.2 | 31.9 | 1.5 | 30.4 |
| Ampicillin | 26.1 | 13.0 | 5.6 | 55.1 |
| Cloxacillin | 0.0 | 43.5 | 13.0 | 43.5 |
| Cefuroxime | 60.8 | 2.9 | 17.4 | 18.8 |
| Cefotaxime | 78.3 | 5.8 | 7.3 | 8.7 |
| Nalidixic acid | 27.5 | 8.7 | 14.5 | 49.3 |
Production of β-lactamase against individual β-lactam substrates.
| Antibiotic hydrolyzed | No. of isolates producing β-lactamase (%) | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Miscellaneous (n = 29) | Total (n = 69) | |||||
| Penicillin | 14 (77.8) | 10 (90.9) | 4 (100.0) | 6 (85.7) | 19(65.5) | 53(76.8) |
| Ampicillin | 8 (44.4) | 9 (81.8) | 2 (50.0) | 6 (85.7) | 18(62.1) | 43(62.3) |
| Cefuroxime | 2 (11.1) | 2 (18.2) | 0 (0.0) | 2 (28.6) | 7(24.1) | 13(18.8) |
| Cefodroxil | 6 (33.3) | 6 (54.5) | 4 (100.0) | 2 (28.6) | 18(62.1) | 36(52.2) |
| Cefotaxime | 3 (16.7) | 2 (18.2) | 0 (0.0) | 3 (42.9) | 7(24.1) | 15(21.7) |
n, number of isolates.
ESβL production by drug resistant enteric bacteria.
| Strain designation | Resistance pattern | β-Lactam substrate hydrolyzed | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Pn | A | Ce | Ced | Cef | ||
| Pn, A, Ce, Cef, Co, Na | ||||||
| Pn, A, Ce, Cef, M, Co, Cfx, Na | − | |||||
| Pn, A, M, Ce, Cef | ||||||
| Pn, A, M, Ce, Co, Cef, Do, Cfx, Nx, Na | ||||||
| Pn, A, M, Co, Nx, Na | − | − | ||||
| Pn, A, M, Co, Ce, T, Cef, Do, C, Nx, Na | ||||||
| Pn, A, Co, Ce, Cef, Cfx, Nx, Na | ||||||
| Pn, A, Co, M, Ce, Cef, Cfx, Nx, Na | − | |||||
| Pn, A, M, Ce, Cef, Co, Cfx, Nx, Na | ||||||
| Pn, A, M, Ce, Cef, T, C, Do, Cfx, Nx, Na | − | |||||
| Pn, A, M, Ce, Co, C, Cef, Do, T, Cfx, Nx, Nf, Na | ||||||
| Pn, A, M, Ce, Co, T, Cef, C, Do, Cfx, Nx, Nf, Na | ||||||
| Pn, A, M, Ce, cef, Co, C, Cfx, Na | ||||||
| Pn, A, M, Ce, Cef, Co, Na | ||||||
| Pn, A, M, Ce, Cef, Co, Na | ||||||
+ = Hydrolysis; − = No hydrolysis.
Pn, penicillin ; A, ampicillin; Ce, cefuroxime; M, methicillin; Co, co-trimoxazole; Cef, cefotaxime; Nx, norfloxacin; Cfx, cefixime; Do, doxycycline; Nf, nitrofurantoin; C, chloramphenicol; T, tetracycline; and Na, nalidixic acid.
Figure 1Agarose gel electrophoresis profiling of plasmids isolated from ESβL producing drug resistant enteric bacteria. Lane a, Super mix lambda DNA; lane b, E. coli; c, Shigella sonnei; d, Citrobacter sp.; e, Salmonella typhimurium; f, Shigella dysenteriae and g, Shigella sp. (plasmid DNA isolated from the enteric bacteria) and lane h, E. coli V 517 reference plasmids. Values marked with arrows show the molecular wt of E. coli V 517 reference plasmids.
Plasmid profiling of selected bacteria of enterobacteriaceae.
| Stains | Number of plasmids | Plasmid mol. wt. |
|---|---|---|
| 5 | 43.79, 8.17, 3.14, 2.61, 1.74 | |
| 2 | 38.30, 0.84 | |
| 5 | 57.24, 6.29, 3.34, 2.63, 1.77 | |
| 3 | 41.88, 6.32, 2.63 | |
| 3 | 45.79, 6.32, 2.63 | |
| 1 | 47.88 |
Transferable nature of antibiotic resistance markers and β-lactamase production among 15 ESβL producing isolates of enteric bacteria
| β-lactamase producing | Characteristics of trans conjugants of | ||||||
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| Donor strain | Resistance pattern | B-lactamase production against | Transferred marker | Transfer frequency of Amp marker | β-lactamase production against | ||
|
|
| ||||||
| Pn | A | A | Pn | A | |||
| Pn, A, M, Ce, Co, Do, Nx, Na | + | + | + | 2.6 × 10−4 | + | + | |
| Pn, A, M, Co, Nx, Na | + | + | + | 1.5 × 10−5 | + | + | |
| Pn, A, M, Ce, Co, C, Cef, Do, T, Cfx, Nx, Nf, Na | + | + | + | 1.8 × 10−5 | + | + | |
| Pn, A, M, Ce, Co, Nf, Na | + | + | + | ND | + | + | |
| Pn, A, Co | + | + | + | 7.0 × 10−3 | + | + | |
| Pn, A, K | + | + | + | 8.8 × 10 −4 | + | + | |
ND = Not determined. Pn, penicillin ; A, ampicillin; Ce, cefuroxime; M, methicillin; Co, co-trimoxazole; Cef, cefotaxime; Nx, norfloxacin; Cfx, cefixime; Do, doxycycline; Nf, nitrofurantoin; C, chloramphenicol; T, tetracycline; K, kanamycin and Na, nalidixic acid.